Illumina Inc. (ILMN) announced Monday that it has entered into a partnership with IBM Corp. (IBM) to standardize genomic data interpretation. The companies will integrate Watson for Genomics into Illumina's BaseSpace Sequence Hub and tumor sequencing process.
from RTT - Before the Bell http://ift.tt/2iFgOdL
via IFTTT
No comments:
Post a Comment